Tuesday, June 11 12:30–1:45pm
P.A.C.T.: Practical Approaches to Comprehensive Treatment of Pain (Part 1)
Tuesday, June 11 2–4:15pm
P.A.C.T.: Practical Approaches to Comprehensive Treatment of Pain (Part 2)
Tuesday, June 11 10–11am
Alzheimer Disease in Primary Care: Early Identification and New Anti-Amyloid Treatment Options
Tuesday, June 11 12:30–1:45pm
P.A.C.T.: Practical Approaches to Comprehensive Treatment of Pain (Part 1)
Tuesday, June 11 2–4:15pm
P.A.C.T.: Practical Approaches to Comprehensive Treatment of Pain (Part 2)
Tuesday, June 11 12:30–1:45pm
P.A.C.T.: Practical Approaches to Comprehensive Treatment of Pain (Part 1)
Tuesday, June 11 2–4:15pm
P.A.C.T.: Practical Approaches to Comprehensive Treatment of Pain (Part 2)
Wednesday, June 12 7:30–8:30am
Demystifying Arrhythmias: A Practical Approach for Primary Care Clinicians
Tuesday, June 11 8–9am
Two Sides of the Same Coin: A Dual-Focused Approach for Diabetes and Weight Management
Wednesday, June 12 1–2pm
Spotting the Difference: Common Dermatologic Rashes and Infections
Wednesday, June 12 9:45–10:45am
Multi-Cancer Early Detection: Overcoming Barriers to Cancer Screening
Tuesday, June 11 8–9am
Two Sides of the Same Coin: A Dual-Focused Approach for Diabetes and Weight Management
Tuesday, June 11 11–11:30am
Keeping Up with the Guidelines: Notable Updates for Primary Care Clinicians
Wednesday, June 12 2:15–3:15pm
Curbside Consults: Top Questions from PCPs on Kidney Disease
Tuesday, June 11 7:30–8am
Test Your Knowledge: Labs & Imaging, Pulmonology, Rheumatology and More!
Tuesday, June 11 10–11am
Alzheimer Disease in Primary Care: Early Identification and New Anti-Amyloid Treatment Options
Tuesday, June 11 4:30–6pm
Taking the Dialogue to the Next Level: Facilitating Open Communication About Obesity
Wednesday, June 12 8:30–9:30am
Aging Minds, Unique Challenges: Addressing Psychiatric Disorders in the Elderly Population
Wednesday, June 12 9:45–10:45am
Multi-Cancer Early Detection: Overcoming Barriers to Cancer Screening
Disclosures
The following financial relationships have been disclosed by faculty, and all have been mitigated by Pri-Med Institute. Relevant relationships will be disclosed at the start of each presentation.
Financial Disclosures
- Charles E. Argoff, MD, FABPM
- AbbVie, Amgen, Averitas Pharma, Biohaven, Grunenthal, Impel Pharmaceuticals, Kowa Pharmaceuticals America, Lilly, Lundbeck, Nevro, and Teva., Speaker; AbbVie, Amgen, Averitas Pharma, Clexio Biosciences, EnZen Therapeutics, Kowa, Lundbeck, Nevro, Tremeau Pharmaceuticals, Tris Pharma, Vertex and Xgene Pharma., Advisor; AbbVie, Amgen, Lilly, Lundbeck, and Teva., Researcher; Neumentum, PainScript, and Tris Pharma, Consultant; Pfizer and Trevena., Stock Holder (publicly traded company)
- Anelyssa D'Abreu, MD, MPH, PhD
- No relevant financial relationships disclosed.
- Oscar A. de Leon-Casasola, MD
- Kowa Pharmaceuticals, Advisor; Kowa Pharmaceuticals, Consultant
- Katherine E. Galluzzi, DO, CMD, FACOFP
- No relevant financial relationships disclosed.
- Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
- OptumRx, Consultant; Premier, Inc., Consultant
- Jennifer B. Green, MD
- Boehringer Ingelheim, Researcher; Lilly, Novo Nordisk, AstraZeneca, and Boehringer Ingelheim, Consultant
- Jonette Keri, MD, PhD
- Almirall, Advisor; L'Oreal, Advisor; Ortho Dermatologics, Advisor; Primus Pharmaceuticals, Advisor
- Mylynda B. Massart, MD, PhD
- GRAIL, LLC, Speaker
- Vani Potluri, MD
- No relevant financial relationships disclosed.
- Rajeev Raghavan, MD, M.Ed, FASN, FACP
- GlaxoSmithKline, Advisor
- Charles Vega, MD, FAAFP
- GlaxoSmithKline and Boehringer Ingelheim, Consultant
- Shirah Vollmer, MD
- No relevant financial relationships disclosed.
- Candace Westgate, DO, MPH, FACOG
- GRAIL, Consultant; GRAIL, Speaker
Other Disclosures
Pamela Kushner, MD, FAAFP (Moderator, Reviewer): Speaker for Astellas, Bayer, and Corcept; Speaker & Advisor for AstraZeneca, GlaxoSmithKline, Janssen, Novo Nordisk, Lilly/BI, and Phathom; Speaker & Consultant for Haleon; Advisor for Abbott, Bausch/SALIX, Intuity, and Pfizer; Consultant for Abbott, AstraZeneca, Bayer, Boehringer Ingelheim, GlaxoSmithKline, and Lilly.
All other non-faculty contributors involved in the moderating, planning, development, editing and review of the content have disclosed no relevant financial relationships.